TAIPEI, June 3, 2024 /PRNewswire/ — Gemtek Technology (TWSE:4906) will host an exclusive closed-door event at its Nan Kang office in collaboration with the medical AI company, Dr. AI, during the 2024 Computex Taipei Exhibition. Together, Gemtek and Dr. AI will showcase their latest co-creation: the Wi-Fi 7 AI Router with voice-enabled AI-Powered Healthcare Service.

Gemtek has long been dedicated to revolutionizing home network solutions through innovation. In an effort to further expand its products and services, Gemtek has transformed its latest Wi-Fi 7 AI Router from a mere connection accessory to a state-of-the-art centerpiece for smart indoor applications. The new Wi-Fi 7 AI Router combines the latest Wi-Fi 7 technology with AI capabilities, offering users voice-enabled AI functions alongside its exceptionally high-speed, stable internet connections.

In envisioning the future of AI-driven human interaction, Gemtek has partnered with Dr. AI, a leading AI-powered healthcare platform, to deliver precise medical analyses and healthcare recommendations through the new Wi-Fi 7 AI Router. This innovative solution aims to assist users in monitoring and managing their health more effectively.

The Gemtek special event will take place at its Nan Kang office during the Computex Taipei Exhibition, spanning three days. This private gathering will showcase professional demonstrations and presentations, providing guests with the opportunity to experience the performance and features of this innovative product firsthand.

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Regional and Global Experts Convene in Accra, Ghana to Update Cancer Treatment Guidelines for Sub-Saharan Africa

Ongoing international oncology collaboration works to empower health care workers and save…

Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil

"Aiming to offer a Dengue antiviral treatment course in $100 price range"…

Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms

Results Highlights for Interim Results ended 30 June 2024 Revenue reached RMB981.8…